Beyond Disclosure: Developing Law and Policy to Tackle Corporate Influence

Area of Science:

• Public Health
• Medical Ethics
• Health Policy

Background:

• Corporate influence poses significant challenges across various public health issues, including obesity and the opioid epidemic.
• Industry entities often fund research and interventions that address problems they create or worsen.
• Existing ethical frameworks and policy responses to industry relationships are evolving but lag behind the issue's complexity.

Purpose of the Study:

• To develop a temporal account of corporate influence and its impact on public health policy.
• To analyze the limitations of conflicts of interest disclosure as a sole response to corporate influence.
• To advocate for structural and systemic solutions beyond mere disclosure.

Main Methods:

• Analysis of the evolution of ethical discourse surrounding industry relationships.
• Examination of legal and policy responses to corporate influence.
• Development of a temporal framework to understand corporate influence and policy reactions.

Main Results:

• Conflicts of interest disclosure has limitations and adverse effects when used as the primary policy tool.
• Disclosure can highlight corporate influence but is insufficient for its elimination.
• Current legal and policy frameworks have not adequately addressed the pervasive nature of corporate influence.

Conclusions:

• Policymakers must move beyond reliance on disclosure to address corporate influence effectively.
• Structural and systemic responses, such as sequestration and separation from private-sector entities, are crucial.
• A comprehensive approach is needed to mitigate the adverse effects of corporate influence on public health.